Key result
CT-derived sarcopenia and adiposity are not linked to 30-day mortality after acute mesenteric ischemia surgery.
Why the study?
CT-derived body composition parameters are proposed prognostic markers in surgical patients, but their role in acute mesenteric ischemia remains unclear.
Do CT-derived body composition parameters (sarcopenia, VAT, SAT) predict short-term outcomes in surgically treated acute mesenteric ischemia?
Cohort
No
Do CT-derived body composition parameters (sarcopenia, VAT, SAT) predict short-term outcomes in surgically treated acute mesenteric ischemia?
CT-derived body composition parameters like sarcopenia and adiposity do not independently predict short-term outcomes in fulminant operative acute mesenteric ischemia, likely because acute physiologic deterioration outweighs baseline metrics.
CT body composition parameters should not guide short-term prognosis after acute mesenteric ischemia surgery; leaves open their value in elective or milder cohorts.
Background Computed tomography–derived body composition parameters, including sarcopenia and adipose tissue distribution, have been proposed as prognostic markers in surgical patients; however, their role in AMI remains unclear. This study aimed to evaluate the association of sarcopenia, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) with short-term outcomes in surgically treated AMI. Methods This retrospective cohort study included consecutive adult patients who underwent surgery for AMI between 2015 and 2025 at a tertiary referral center. Preoperative CT scans were used to assess skeletal muscle index (SMI), VAT, and SAT at the third lumbar vertebra level. Sarcopenia was defined using established CT-based SMI thresholds. Visceral adipose tissue and SAT adiposity were defined as areas ≥100 cm 2 . The primary outcome was 30-day mortality, and the secondary outcome was length of hospital stay (LOS). Results Sarcopenia was present in 76.7% of patients. The 30-day mortality rate was 54.8%. Sarcopenia was not associated with 30-day mortality or LOS ( P > 0.05). Similarly, neither VAT nor SAT adiposity was associated with mortality or LOS. Patients who died within 30 days were significantly older ( P = 0.004) and had significantly lower serum albumin levels ( P = 0.008). Length of hospital stay was significantly shorter in non-survivors ( P < 0.001). Discussion Although sarcopenia and abnormal adipose tissue distribution were highly prevalent, CT-derived morphometric parameters did not independently discriminate short-term outcomes in surgically treated AMI. These findings suggest that in fulminant operative AMI, acute ischemic burden, and systemic physiologic deterioration may outweigh the prognostic contribution of baseline body composition metrics.
No takes yet. Share an insight, caveat, or question.
Gür et al. (2026) conducted a cohort in Acute mesenteric ischemia. Sarcopenia and abnormal adipose tissue distribution vs. Normal body composition was evaluated on 30-day mortality (p=> 0.05). CT-derived sarcopenia and abnormal adipose tissue distribution were not associated with 30-day mortality in patients with surgically treated acute mesenteric ischemia (P>0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: